WATC34 Stock Overview
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Waters Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$394.00 |
| 52 Week High | US$401.98 |
| 52 Week Low | US$384.09 |
| Beta | 0.96 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -5.99% |
| 5 Year Change | n/a |
| Change since IPO | 84.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| WATC34 | BR Life Sciences | BR Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how WATC34 performed against the BR Life Sciences industry.
Return vs Market: Insufficient data to determine how WATC34 performed against the BR Market.
Price Volatility
| WATC34 volatility | |
|---|---|
| WATC34 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in BR Market | 0% |
| 10% least volatile stocks in BR Market | 0% |
Stable Share Price: WATC34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine WATC34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 7,900 | Udit Batra | www.waters.com |
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Waters Corporation Fundamentals Summary
| WATC34 fundamental statistics | |
|---|---|
| Market cap | R$98.22b |
| Earnings (TTM) | R$3.39b |
| Revenue (TTM) | R$15.61b |
29.0x
P/E Ratio6.3x
P/S RatioIs WATC34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WATC34 income statement (TTM) | |
|---|---|
| Revenue | US$2.96b |
| Cost of Revenue | US$1.20b |
| Gross Profit | US$1.76b |
| Other Expenses | US$1.12b |
| Earnings | US$642.23m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | 10.83 |
| Gross Margin | 59.57% |
| Net Profit Margin | 21.72% |
| Debt/Equity Ratio | 205.9% |
How did WATC34 perform over the long term?
See historical performance and comparison